Complementary Roles for Tissue- and Blood-Based Comprehensive Genomic Profiling for Detection of Actionable Driver Alterations in Advanced NSCLC

Complementary Roles for Tissue- and Blood-Based Comprehensive Genomic Profiling for Detection of Actionable Driver Alterations in Advanced NSCLC

Introduction: Whereas tumor biopsy is the reference standard for genomic profiling of advanced NSCLC, there are now multiple assays approved by the Food and Drug Administration for liquid biopsy testing of circulating tumor DNA. Here, we study the incremental value that liquid biopsy comprehensive g...

Full description

Bibliographic Details
Main Authors: Lee S. Schwartzberg, MD, Gerald Li, PhD, Khaled Tolba, MD, Ariel B. Bourla, MD, PhD, Katja Schulze, PhD, Rujuta Gadgil, MS, Alexander Fine, PhD, Katherine T. Lofgren, PhD, Ryon P. Graf, PhD, Geoffrey R. Oxnard, MD, Davey Daniel, MD
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:JTO Clinical and Research Reports
Subjects:
Comprehensive genomic profiling
Liquid biopsy
Biomarkers
Tissue-based testing
NSCLC
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364322001102

Internet

http://www.sciencedirect.com/science/article/pii/S2666364322001102

Similar Items